Treatment-related adverse events
| Adverse event* | All grades† (%) | Grade ≥3 (%) |
| Fatigue | 6 (24) | |
| Hypothyroidism | 5 (20) | |
| Maculo-papular rash | 4 (16) | 1 (4) |
| Aspartate aminotransferase increased | 3 (12) | |
| Alanine aminotransferase increased | 2 (8) | |
| Anorexia | 2 (8) | |
| Diarrhea | 2 (8) | 1 (4) |
| Acute kidney injury‡ | 1 (4) | 1 (4) |
| Arthralgia | 1 (4) | |
| Bullous dermatitis | 1 (4) | |
| Creatinine increased | 1 (4) | |
| Fever | 1 (4) | |
| Hyperthyroidism | 1 (4) | |
| Pneumonitis‡ | 1 (4) | 1 (4) |
| Skin infection | 1 (4) |
*Treatment-related adverse events (TRAEs) listed here include all those that occurred on study patients regardless of grade and all grade ≥3 events. All TRAEs are coded and graded as per the Common Terminology Criteria for Adverse V.4.0.
†No grade 4 or 5 TRAEs occurred on study.
‡Two (8%) patients had treatment-related serious adverse events.